Dow Corning Healthcare experts will be presenting their latest research and findings at the 2009 AAPS Annual Meeting and Exposition, November 8-12, at the Los Angeles Convention Center in Los Angeles, California.
On Tuesday, November 10, during the afternoon session, which will run from 1-4 p.m., Dow Corning industry specialist, Gerald Schalau will present the poster “Performance evaluation of automated static Franz-cell equipment for in vitro release and skin penetration testing.” During the same session, Dow Corning’s Regina Malczewski will present the poster “Use of Phage Display for Targeted Binding to Substrates of Medical and Pharmaceutical Significance.”
Dow Corning offers one of the most expansive lines of silicon-based performance enhancing materials in the healthcare industry – materials that are safe and beneficial in numerous applications. Product offerings include adhesives; antifoams and antifoam emulsions; fluids, emulsions and dispersions; topical excipients; rubber and elastomers; and tubing and molded assemblies.
These materials are manufactured under strict quality control guidelines at Dow Corning’s Healthcare Industries Materials Site (HIMS) in Hemlock, Michigan. This site is dedicated to the production of silicone materials for healthcare applications and is registered with the FDA as a Drug Establishment. The quality system is based on principles of current Good Manufacturing Practices (cGMPs) for both Bulk Pharmaceutical Products and Medical Devices, and the site is ISO 9001 registered.
Further information about Dow Corning healthcare solutions can be found in the Healthcare Product Selector Guide or visit www.dowcorning.com/healthcare.
About Dow Corning
Dow Corning (dowcorning.com) provides performance-enhancing solutions to serve the diverse needs of more than 25,000 customers worldwide.
A global leader in silicones, silicon-based technology and innovation, Dow Corning offers more than 7,000 products and services via the company’s Dow Corning® and XIAMETER® brands. Dow Corning is a joint venture equally owned by The Dow Chemical Company and Corning, Incorporated. More than half of Dow Corning’s annual sales are outside the United States.